Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-28

Clinical Trial Update: Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating switching from tenofovir disoproxil fumarate to abacavir or tenofovir alafenamide in individuals with chronic renal insufficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
  • Tenofovir alafenamide (tenofovir alafenamide)
  • abacavir (abacavir)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Renal Insufficiency,Chronic, Hiv | Phase 4 | Status: UNKNOWN